Evaluation of Parenteral Depot Insulin Formulation using PLGA and PLA Microparticles

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Biomaterials Applications

• Publication date

  2009-11-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1177/0885328208096238PMID 18987018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles

  2008cited by this paper
• How to achieve sustained and complete protein release from PLGA-based microparticles?

  2008cited by this paper
• Modified assay procedure for the estimation of serum glucose using microwell reader

  2008cited by this paper
• Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin.

  2006cited by this paper
• Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles

  2005cited by this paper
• Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres.

  2005cited by this paper
• Formulation aspects of biodegradable polymeric microspheres for antigen delivery.

  2005cited by this paper
• PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis.

  2005cited by this paper
• Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.

  2005cited by this paper
• Protein drug stability: a formulation challenge

  2005cited by this paper
• Current advances in sustained-release systems for parenteral drug delivery

  2005cited by this paper
• In situ-Forming Pharmaceutical Organogels Based on the Self-Assembly of L-Alanine Derivatives

  2004cited by this paper
• Microparticles for the delivery of DNA vaccines

  2004cited by this paper
• Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres.

  2004cited by this paper
• The Physiological Rationale for Oral Insulin Administration

  2004cited by this paper
• Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres

  2004cited by this paper
• A hydrogel prepared by in situ cross-linking of a thiol-containing poly(ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery.

  2003cited by this paper
• Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

  2003cited by this paper
• Sustained delivery of human growth hormone from a novel gel system: SABER.

  2002cited by this paper
• Pegnology: a review of PEG-ylated systems.

  2002cited by this paper
• Design of biodegradable particles for protein delivery.

  2002cited by this paper
• Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems.

  2002cited by this paper
• Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 2. Viability of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate).

  2002cited by this paper
• Protein drug oral delivery: The recent progress

  2002cited by this paper
• Controlled delivery of metoclopramide using an injectable semi-solid poly(ortho ester) for veterinary application.

  2002cited by this paper
• Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.

  2002cited by this paper
• Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium.

  2001cited by this paper
• Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide.

  2000cited by this paper
• Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles

  2000cited by this paper
• Stabilization of dichloromethane-induced protein denaturation during microencapsulation.

  1998cited by this paper
• A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye

  1997cited by this paper
• Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides.

  1997cited by this paper
• The new era of biotech insulin analogues

  1997cited by this paper
• Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo.

  1995cited by this paper
• The colloidal properties of surfactant-free biodegradable nanospheres from poly(β-malic acid-co-benzyl malate)s and poly(lactic acid-co-glycolide)

  1995cited by this paper
• Monomeric Insulins and Their Experimental and Clinical Implications

  1990cited by this paper
• Cleavage of structural proteins during

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Injectable Systems for Long-lasting Insulin Therapy.

  2023cites this paper
• Development of Biodegradable Delivery Systems Containing Novel 1,2,4-Trioxolane Based on Bacterial Polyhydroxyalkanoates

  2022cites this paper
• Preclinical study of influenza bivalent vaccine delivered with a two compartmental microneedle array.

  2020cites this paper
• Preparation, characterization and ecotoxicological evaluation of four environmentally relevant species of N-isopropylacrylamide and N-isopropylacrylamide-co-N-tert-butylacrylamide copolymer nanoparticles

  2020cites this paper
• Enhanced transdermal permeation of rasagiline mesylate nanoparticles: design, optimization, and effect of binary combinations of solvent systems across biological membrane

  2020cites this paper
• Towards In Vitro In Vivo Correlation for Modified Release Subcutaneously Administered Insulins.

  2020cites this paper
• In vitro Label Free Raman Microspectroscopic Analysis to Monitor the Uptake, Fate and Impacts of Nanoparticle Based Materials

  2020cites this paper
• Injectable Systems for Long-Lasting Insulin Therapy

  2019cites this paper
• Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers

  2018cites this paper
• When Good Goes Awry: The Aggregation of Protein Therapeutics.

  2017cites this paper
• Is there an impact of encapsulation on parenteral delivery of insulin

  2016cites this paper
• Current approaches for in vitro drug release study of long acting parenteral formulations.

  2015cites this paper
• Hydrochlorothiazide containing PLGA nanoparticles: Design, characterization, in-vitro drug release and release kinetic study

  2015cites this paper
• Degradation behaviors, thermostability and mechanical properties of poly (ethylene terephthalate)/polylactic acid blends

  2014cites this paper
• Degradation behaviors, thermostability and mechanical properties of poly (ethylene terephthalate)/polylactic acid blends

  2014cites this paper
• ENHANCED BURN WOUND HEALING THROUGH CONTROLLED AND SUSTAINED DELIVERY OF BIOACTIVE INSULIN FROM ALGINATE SPONGE DRESSINGS

  2013cites this paper
• Role Of Polymeric Excipients On Controlled Release Profile of Glipizide from PLGA and Eudragit RS 100 Nanoparticles

  2013cites this paper
• Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease.

  2012influential citation
• Interaction of poly(N-isopropylacrylamide) (pNIPAM) based nanoparticles and their linear polymer precursor with phospholipid membrane models.

  2012cites this paper
• Nanoparticle delivery systems formed using electrically sprayed co-flowing excipients and active agent.

  2011cites this paper
• Eco and In Vitro Mammalian Toxicological Assessment of Polymeric Nanomaterials

  2011cites this paper
• Biodegradable implants with different drug release profiles

  2011cites this paper
• Intracellular localisation, geno- and cytotoxic response of polyN-isopropylacrylamide (PNIPAM) nanoparticles to human keratinocyte (HaCaT) and colon cells (SW 480).

  2010cites this paper
• Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds.

  2010cites this paper
• Preparation, characterization of NIPAM and NIPAM/BAM copolymer nanoparticles and their acute toxicity testing using an aquatic test battery.

  2009cites this paper
• ARROW@TU Dublin ARROW@TU Dublin

  year unknowncites this paper